Supplementary Table 11 includes the proportion of time covered measures for the entire cohort, by surveillance type and by payer.</p
Supplementary Table 5 includes baseline characteristics of individuals with cirrhosis eligible for H...
Supplementary Table 17 includes two-year cumulative incidences by cirrhosis etiology and by insuranc...
Supplementary Table 7 includes baseline characteristics of individuals with cirrhosis eligible for H...
Supplementary Table 4 includes descriptive statistics of the cohort, by cirrhosis etiology and by in...
Supplementary Table 8 includes one-year cumulative incidences for HCC surveillance overall and by in...
Supplementary Table 12 includes the one-year cumulative incidences for HCC surveillance overall and ...
Supplementary Table 10 includes two-year cumulative incidences by cirrhosis etiology and by insuranc...
Supplementary Table 3 includes hypothetical examples for calculating the Proportion of Time Covered ...
Supplementary Table 9 includes two-year cumulative incidences for HCC surveillance overall and by in...
Supplementary Table 13 includes the two-year cumulative incidences for HCC surveillance overall and ...
Supplementary Table 14 includes the two-year cumulative incidences by cirrhosis etiology and by insu...
Supplementary Table 15 includes one-year cumulative incidences for HCC surveillance overall and by i...
Supplementary Table 16 includes two-year cumulative incidences for HCC surveillance overall and by i...
The Supplementary Methods includes detailed descriptions for calculating the Proportion of Time Cove...
Supplementary Table 1 includes the validated algorithms and ICD-9-CM and ICD-10-CM codes for cirrhos...
Supplementary Table 5 includes baseline characteristics of individuals with cirrhosis eligible for H...
Supplementary Table 17 includes two-year cumulative incidences by cirrhosis etiology and by insuranc...
Supplementary Table 7 includes baseline characteristics of individuals with cirrhosis eligible for H...
Supplementary Table 4 includes descriptive statistics of the cohort, by cirrhosis etiology and by in...
Supplementary Table 8 includes one-year cumulative incidences for HCC surveillance overall and by in...
Supplementary Table 12 includes the one-year cumulative incidences for HCC surveillance overall and ...
Supplementary Table 10 includes two-year cumulative incidences by cirrhosis etiology and by insuranc...
Supplementary Table 3 includes hypothetical examples for calculating the Proportion of Time Covered ...
Supplementary Table 9 includes two-year cumulative incidences for HCC surveillance overall and by in...
Supplementary Table 13 includes the two-year cumulative incidences for HCC surveillance overall and ...
Supplementary Table 14 includes the two-year cumulative incidences by cirrhosis etiology and by insu...
Supplementary Table 15 includes one-year cumulative incidences for HCC surveillance overall and by i...
Supplementary Table 16 includes two-year cumulative incidences for HCC surveillance overall and by i...
The Supplementary Methods includes detailed descriptions for calculating the Proportion of Time Cove...
Supplementary Table 1 includes the validated algorithms and ICD-9-CM and ICD-10-CM codes for cirrhos...
Supplementary Table 5 includes baseline characteristics of individuals with cirrhosis eligible for H...
Supplementary Table 17 includes two-year cumulative incidences by cirrhosis etiology and by insuranc...
Supplementary Table 7 includes baseline characteristics of individuals with cirrhosis eligible for H...